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SUMMARY 
The interferon system is amenable to somatic cell genetic 
analysis since the genes governing the synthesis of interferon 
and the cellular responses to interferon can be expressed in 
tissue culture cells. Limited sre cies spscificity exists in 
the interferon system, allowing interspecific hybrid cells to 
be used in mapping genes involved in interferon production and 
mechanism of action. 
The synthesis of interferon and the attainment of the 
antiviral state following interferon treatment are separate 
genetic functions, governed by genes on different chromosomes. 
Three different human chromosomes have been implicated in the 
production of human fibroblast interferon based on studies using 
interspecific somatic cell hybrids. The recent cloning of 
multiple interferon gene sequences will provide probes for 
further gene mapping. Genes governing sensitivity of cells to 
interferon have been mapped to human chromosome 21 and mouse 
chromosome 16. 
When human/mouse somatic cell hybrids are injected into 
mice of thd same strain as the murine parent of the hybrid, 
antibodies directed against cell surface components coded by 
the retained human chromosomes are produced. Antibodies raised 
against human chromosome 21-coded cell surface determinants can 
b!~c~ ~~man interferon ~ction on h~man fi~roblasts, pres~ma~7y 
by blocking a human interferon receptor. Monoclonal antibodies 
against this receptor can be produced and used to study the 
role of receptors in interferon action. 
INTRODUCTION 
Interferons comprise a group of proteins and glycoproteins 
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which exert a wide range of biological effects on target cells. 
They were first described by Isaacs and Lindenmannin 1957, and 
are best known for their ability to induce an antiviral state 
in sensitive cells. Cells in the antiviral state are unable to 
support growth and replication of a wide range of viruses. The 
synthesis of interferon can be induced by viral infection, 
exposure to double-stranded RNA, or by other stimuli, depending 
on the cells involved. Interferon is released from the produc-
ing cell and binds to cell surface receptors on other cells. 
This binding triggers a number of intracellular events in the 
responding target cell, including transcription and transla-
tion of new proteins, and the modification of some constitutive 
proteins (BAGLIONI 1979). Interferon also affects cell pro-
liferation and can modulate the immune response (see STEWART 
1979) . 
Interferon synthesis in response to various inducers and 
the attainment of the antiviral state following interferon 
treatment both require de novo RNA and protein synthesis. Mes-
senger RNA i ,solated from cells after induction can be trans-
lated in c~Jl-free systems, in Xenopus oocytes, or after micro-
injection /4nto heterologous cells to give functionally active 
interferon. Several groups have cloned interferon sequences, 
both in the form of cDNA and genomic DNA (see DERYNCK et al. 
1980, TANIGUCHI et al. 1980). Cloned sequences have been in-
serted into bacteria and can be expressed (see NAGATA et al. 
1980). 
Interferon is assayed by its biological activity, usually 
by quantitating its ability to protect cells from virus chal-
lenge. One unit is defined as that amount which reduces a 
virus growth parameter (for example, cytopathic effect on a 
cell monolayer or number of plaques) by 50 per cent compared 
with controls. Purified interferon has a specific activity of 
approximately 10 8 - 10 9 units/mg protein. Given an average 
molecular weight of 20,000 daltons (range 15,000-35L000), 
interferon is active at concentrations as low as 10 13 or 
10- 14 M. 
The mechanism of action of interferon is not definitively 
known, although numerous studies have revealed interesting 
biochemical changes in interferon-treated cells. Depending on 
the cells and viruses being studied, the inhibition of viral 
replication has been reported to occur at many levels: tran-
scription, translation, and assembly or budding of mature 
virions (see STEWART 1979). Several possible pathways for , 
translational inhibition in interferon-treated cells have been 
described: double-stranded Rl"\/A-dependent phosphorylation of an 
initiation factor (elF-2) subunit which inhibits initiation 
complex formation; activation of an endoribonuclease by 
pppA(2'p5'A)n, a molecule synthesized by an enzyme dependent 
on double-stranded RNA, and degradation of the -CCA amino acid 
accepting end of transfer RNA molecules by a phosphodiesterase. 
Within a given species, several types of interferon can 
be produced, depending on cell type and inducing stimulus. In 
the human interferon system, three major antigenic types of 
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interferon have been described: a (leukocyte), B (fibroblast), 
and y (immune). The usual cells of origin for these thr8e types 
are buffy coat leukocytes or established lymphoblastoid lines, 
f{broblasts, and T ~~lls, respectively. A single cell type may 
produce more than one type of interferon, depending on what 
inducer is used to trigger interferon synthesis (HAVELL, HAYES 
& VILCEK 1978). 
SOMATIC CELL GENETIC STUDIES 
Since interferon production and response are inducible 
phenotypes which can be studied in tissue culture cells, so-
matic cell genetic techniques can be employed to define and 
map loci involved in the interferon system. Limited species 
specificity (human interferons generally being more active on 
human cells than on mouse cells and vice versa) suggested that 
interspecific heterokaryons and hybrids could be used in the 
gene mapping studies. 
Cells of two species can be fused with inactivated Sendai 
virus, polyethylene glycol, or other agents to form hetero-
karyons. After the genetic material from both parental cells 
is combined in a single nucleus, the resulting hybrid cell 
undergoes partial loss of one parental chromosome set. This 
"parasexual" system involving chromosome segregation permits 
gene mapping for the species whose chromosomes are lost. By 
correlating the presence of marker isozymes and an interferon 
phenotype, synteny assignments can be made for the genes in-
volved. Identification of the specific chromosomes retained in a 
hybrid through banding and differential staining techniques is 
then used ,to assign genes to given chromosomes. 
Early studies with human/chick heterokaryons (GUGGENHEIM 
et al. 1968) suggested that interferon structural genes from 
both parents could be expressed simultaneously. Heterokaryons 
and hybrids could also respond to the interferons of both par-
ental types (GUGGENHEIM et al. 1969, CARVER et al. 1968). 
Monkey/mouse hybrid cells segregating monkey chromosomes 
were used to make the first chromosome assignment for a gene 
governing the synthesis of monkey interferon (CASSINGENA et al. 
1971). The monkey gene governing the establishment of the anti-
viral state was determined to be asyntenic to the gene for 
interferon production. 
Experiments with human/mouse somatic cell hybrids segre-
gating human chromosomes indicated a concordant segregation of 
the interferon-induced "antiviral protein" and indophenol oxi-
dase B (cytoplasmic superoxide dismutase). These genes were 
assigned to human chromosome 21 (TAN, TISCHFIELD, & RUDDLE 
1973, CHANY et al 1975). TAN et al. (1974) then examined the 
effect of chromosome 21 dosage on the expression of the human 
interfe·ron induced antiviral state. The amount of interferon 
required by diploid human cell lines was 3 to 7 times higher 
than for trisomy 21 cell lines; monosomy 21 cells require even 
higher doses of interferon. 
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The product of the gene on chromosome 21 responsible for 
conferring sensitivity to human interferon has not been isolated,' 
al though a cell surface receptor, for interferon is the most ' 
likely candidate. Different levels of interferon binding have 
been recorded for cells with different numbers of copies of 
chromosome 21 (WIRANOWSKA-STEWART & STEWART 1977). The gene gov-
erning human interferon sensitivity has been regionally mapped 
to the long arm of chromosome 21 (TAN & GREENE 1976, EPSTEIN & 
EPSTEIN 1976). Sensitivity to both leukocyte and fibroblast 
interferons appears to map to this region. 
SLATE et al. (1978) demonstr&ted that a human/mouse somat-
ic cell hybrid which retains chromosome 21 as the only detect-
able human genetic material could respond to human leukocyte 
and fibroblast interferons. The response was measured by inhi-
bitionof vesicular stomatitis virus yields and virus-induced 
bytopathic effects, and by assessing biochemical changes in 
extracts from interferon-treated cells. Human interferon could 
trigger mouse-specific elements of the antiviral response in 
this 21-only hybrid cell line. 
Injecting mice with human/mouse somatic cell hybrids 
results in the- productiorr of antibodies which are directed 
against human cell surface components, provided that the mice 
are of the same strain as the murine parent of the hybrid. 
Antibodies raised against hybrid cells retaining human chromo-
somes 4, 21, and 22 could block the action of human interferon 
in diploid human fibroblasts (REVEL, BASH & RUDDLE 1976). This 
blocking activity was more pronounced in monosomy 21 cells and 
decreased as the number of copies of chromosome 21 increased. 
This is consistent with the gene dosage effect seen for human 
interferon sensitivity. Preabsorption of the antiserum on cells 
with chromosome 21 could remove its blocking activity, while 
preabsorption on cells retaining chromosomes 4 and 22 (but lack-
ing 21) could not. These studies have been extended to anti-
sera raised against human/mouse hybrids retaining human chromo-
somes 21 and 22 or just 21 alone with similar results (SLATE & 
RUDDLE 1978). 
Although the usual pattern for chromosome segregation in 
human/rodent hybrid cells involves the preferential loss of 
human chromosomes, "reverse" segregant hybrids can be construct-
ed by fusing primary mouse cells to transformed human cells. 
Using this approach, LIN et al. (1979) mapped the mouse gene 
responsible for conferring sensitivity to interferon to murine 
chromosome 16. COX et al. (1979) have also mapped the mouse 
interferon sensitivity gene to chromosome 16 using mouse/ 
Chinese hamster hybrids segregating mouse chromosomes. Both 
groups found a syntenic relationship for the genes coding for 
mouse interferon sensitivity and cytoplasmic superoxide dis-
ootase. This same syntenic relationship exists for the two 
oorresponding human genes. 
Although the classical somatic cell genetic analyses out-
lined above give clear-cut results for the chromosomal location 
~ the genes governing interferon sensitivity, the location of 
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interferon structural genes is still debated. TAN, CREAGAN & 
RUDDLE (1974) found that human chromosomes 2 and 5 together 
were necessary for human interferon production in human/mouse 
somatic cell hybrids. More recent investigations have suggest-
ed that chromosome 5 alone (MORGAN & FALK 1977, TAN, TAN & 
BERTHOLD 1977) is responsible for human interferon production. 
SLATE & RUDDLE (1979) found evidence for separate fibroblast 
interferon loci on chromosomes 2 and 5. MEAGER et al (1979) 
have presented evidence for a single fibroblast interferon 
locus on human chromosome 9. With the recent discovery that 
interferons comprise a multigene family, it may be possible 
to reconcile these apparent disagreements (GOEDDEL et al. 1981, 
SEHGAL & SAGAR 1980). 
CURRENT RESEARCH EFFORTS 
Our current research on the interferon system is focused 
on two major areas: mapping human interferon structural genes 
by a combination of classical somatic cell genetics and re-
combinant DNA techniques and generating monoclonal antibodies 
against the putative human interferon receptor. We wi ll briefly 
outline the approaches we are taking in these projects. 
As the number of human interferon genes which have been 
cloned by recombinant DNA technology increases, so does the 
number of probes which can be used to map these genes in 
somatic cell hybrids. The basic design of this mapping project 
is outlined in Figure 1. DNA is isolated from a number of 
human/rodent hybrid cells which have been carefully analyzed 
for their retention of human chromosomes. This DNA is digested 
with restriction endonucleases and electrophoresed in agarose 
gels to separate the digested DNA fragments by size. The DNA 
is then transferred onto nitrocellulose filters by Southern 
blotting and hybridized to a radioactively labelled interferon 
PM/EL OF SOMATIC CELL HYBRIDS 
EXTRACT DNA 
-l, 
DIGEST DNA WI'I'H 
RESTRICTION ENZYI:-!ES 
4, 
AGAROSE GEL 
ELECTROPHORESIS 
i-
TRANSFER DNA TO 
NITROCELLULOSE 
FILTERS 
t 
HYBRIDIZE DNA ON 
FILTER TO LABELLED 
CLONED INTERFERON 
GEi,JE PROBE 
~ 
CHRONOSOME SPREAD 
AND ISOZYME ANALYSIS 
.(, 
SUMJ•/!,P,RY OF CHROMOSOME 
cm<POSITION OF HYBRIDS 
Figure 1. Scherae for identifying chromosomal location of 
cloned interferon gene sequence. 
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sequence probe. By comparing the hybridization pattern of the 
different hybrids to human and rodent DNA controls, it is 
possible to determine which hybrids have retained the given 
interferon sequence and to map the sequence to a particular 
human chromosome. Experiments of this type are being done in 
a number of different laboratories for both a and e interferon 
sequences. A major advantage of this mapping strategy is that 
it bypasses the need for expression of the interferon genes in 
a hybrid cell after induction. 
Our second major area of interest in the interferon 
system is the development of monoclonal antibodies against the 
human interferon receptor. These studies are an extension of 
the work with mouse antibodies directed against chromosome 21-
coded cell surface determinants discussed earlier. The basic 
strategy we employ is outlined in Figure 2. Spleen cells are 
removed from mice which have been injected with a human/mouse 
hybrid line retaining only human chromosome 21 andwhich are pro-
ducing antibodies which block human interferon action. These 
cells are fused with an established mouse myeloma line to 
produce hybridomas which secrete antibodies into their tissue 
culture medium. The hybridomas are cloned, and the incubation 
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Figure 2. Strategy tor identifying monoclonal antibodies 
directed against the human interferon receptor. 
nedium tested for the presence of antibodies which block inter-
feron action. Once a line producing monoclonal antibody with 
iood blocking activity is identified, it can be injected into 
nice and be grown as ascitic tumors. 
CONCLUSION 
Somatic cell genetic techniques have permitted the 
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analysis of the genetic control of interferon production and 
response. Coupled with recent developments in recombinant DNA 
technology and immunology, these techniques should allow 
further mapping and a more detailed picture of the regulation 
of interferon gene expression. 
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